09.05.13
Patheon
3Q Revenues: $265.7 million (+30%)
3Q Earnings: $4.3 million (earnings were $15.5 million 3Q12)
YTD Revenues: $733.1 million (+36%)
YTD Loss: $46.9 million (loss of $83.5 million YTD12)
Comments: Revenue growth in the quarter was boosted by the Banner acquisition, which contributed $66.4 million. Commercial manufacturing (CMO) revenues for quarter increased 35% to $227.8 million. Pharmaceutical Development Services (PDS) revenues increased 7% to $37.9 million. YTD Banner revenue contributed $144.2 million. CMO revenues were up 43% to $627.4 million and PDS revenues were up 5% to $105.7 million.
3Q Revenues: $265.7 million (+30%)
3Q Earnings: $4.3 million (earnings were $15.5 million 3Q12)
YTD Revenues: $733.1 million (+36%)
YTD Loss: $46.9 million (loss of $83.5 million YTD12)
Comments: Revenue growth in the quarter was boosted by the Banner acquisition, which contributed $66.4 million. Commercial manufacturing (CMO) revenues for quarter increased 35% to $227.8 million. Pharmaceutical Development Services (PDS) revenues increased 7% to $37.9 million. YTD Banner revenue contributed $144.2 million. CMO revenues were up 43% to $627.4 million and PDS revenues were up 5% to $105.7 million.